Aura Biosciences, Inc. (AURA)
5.94
-0.01
(-0.17%)
USD |
NASDAQ |
Mar 13, 16:00
5.95
+0.01
(+0.17%)
After-Hours: 20:00
Aura Biosciences EPS Diluted (Quarterly) : -0.3963 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.13M |
| Total Expenses (Quarterly) | 26.13M |
| Enterprise Value | 233.10M |
| Earnings Yield | -32.46% |
| Normalized Earnings Yield | -32.46 |